Myotonic Dystrophy type 2 (DM2)

Definition

It results from expansion of the CCTG tetranucleotide repeat in intron 1 of the CNBP (ZNF9) gene. This autosomal dominant multisystem disease presents with progressive proximal muscle weakness, myotonia, myalgia, calf hypertrophy, cataracts, and endocrine involvement; it is generally milder than DM1.

Gene/region examined

CNBP - CCTG Repeat Number Analysis

Method

Fragment Analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary, autosomal dominant.

Related Tests